SNTB1 antisense RNA 1 (SNTB1-AS1)

SNTB1 antisense RNA 1 (SNTB1-AS1) is annotated as a long non-coding RNA that is transcribed antisense to the SNTB1 gene. While some antisense lncRNAs are known to regulate their sense transcript (the corresponding protein-coding gene) or participate in various regulatory roles in health and disease[1][3], there is currently no peer-reviewed research detailing the specific sequence, biological role, disease relevance, or therapeutic targeting of SNTB1-AS1. The aliases AC104958.2 and GDIL are alternate names found mainly in sequence repositories, but do not correspond to curated disease gene resources or drug databases. No information is available regarding SNTB1-AS1 as a drug target, disease biomarker, or as a protein-coding gene. Key notes: SNTB1 (the protein-coding gene) itself is a recognized protein with roles in dystrophin-associated protein complexes and cancer, but SNTB1-AS1 is not described in these contexts[2]. If you seek information on general properties of antisense lncRNAs, there is literature on this RNA class, but nothing specifically for SNTB1-AS1 in disease, signaling, or drug development contexts[1][3]. If you intended to refer to another more established target, double-check the spelling or provide additional context. The available data suggest this is a “dark genome” lncRNA, i.e., annotated but not functionally studied.

Other names

AC104958.2GDIL (GSH Degradation Inhibiting LncRNA)

None described